Orphan Drugs

May 5th, 2018 Istabul, Turkey and Pully, Switzerland: Nobel Ilac and CarthaGenetics® announce collaboration for rare diseases in North Africa area.

Nobel Ilac is a full-cycle Turkish pharmaceutical company founded in 1964, producing world-class pharmaceuticals for human health. Nobel Ilac provides a global presence of outstanding, reliable and accessible products for human health.

CarthaGenetics® is focusing on finding innovative early patients access to medicines for supplying the unmet needs and is a pioneer with having the broadest experience in the field of rare diseases, gene therapies and biosimilars.

Nobel Ilac and CarthaGenetics® announce the collaboration for rare diseases in North Africa area.

For any question concerning this, please contact Burak Levent, at Nobel Ilac burak.levent@nobel.com.tr or Philippe Carteron de Balmont CEO, at CarthaGenetics® phcarteron@carthagenetics.com